Assessment of Lung Aeration at Birth
Bronchopulmonary Dysplasia
About this trial
This is an interventional prevention trial for Bronchopulmonary Dysplasia focused on measuring Lung aeration, Bronchopulmonary dysplasia, Positive Pressure Respiration, Sustained Inflation, Continuous Positive Airway Pressure
Eligibility Criteria
Inclusion Criteria:
- Infants <33 weeks gestation born in the Royal Alexandra Hospital who require respiratory support for resuscitation in the delivery room.
Exclusion Criteria:
- Infants will be excluded if they have a congenital abnormality or condition that might have an adverse effect on breathing or ventilation, e.g. congenital pulmonary or airway anomalies, congenital diaphragmatic hernia, or congenital heart disease requiring intervention in neonatal period. Infants will also be excluded if their parents refuse to give consent to this study.
Sites / Locations
- Royal Alexandra Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
"SI group"
IPPV group
Infants randomized into the "SI group" will receive two initial sustained inflations with a PIP of 20 cm H2O. After the two initial SIs infants will receive PEEP of 5 cm H2O and then CPAP if breathing spontaneously or, if found to have apnea or laboured breathing, mask IPPV with a PIP of 20 cm H2O and PEEP of 5 cm H2O at a rate of 40 to 60 bpm until spontaneously breathing, at which time CPAP will be provided.
Infants randomized into the "IPPV group" will receive mask IPPV with an initial PIP of 20 cmH2O and PEEP of 5 cm H2O, and a ventilation rate of 40-60 inflations/min until spontaneously breathing, at which time CPAP will be provided.